Found: 15
Select item for more details and to access through your institution.
Therapeutic Potential of Phytocannabinoid Cannabigerol for Multiple Sclerosis: Modulation of Microglial Activation In Vitro and In Vivo.
- Published in:
- Biomolecules (2218-273X), 2023, v. 13, n. 2, p. 376, doi. 10.3390/biom13020376
- By:
- Publication type:
- Article
Intracellular spatially-targeted chemical chaperones increase native state stability of mutant SOD1 barrel.
- Published in:
- Biological Chemistry, 2023, v. 404, n. 10, p. 909, doi. 10.1515/hsz-2023-0198
- By:
- Publication type:
- Article
All Roads Lead to Rome: Different Molecular Players Converge to Common Toxic Pathways in Neurodegeneration.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 9, p. 2438, doi. 10.3390/cells10092438
- By:
- Publication type:
- Article
MIF inhibits the formation and toxicity of misfolded SOD1 amyloid aggregates: implications for familial ALS.
- Published in:
- Cell Death & Disease, 2018, v. 9, n. 2, p. 1, doi. 10.1038/s41419-017-0130-4
- By:
- Publication type:
- Article
Why lithium studies for ALS treatment should not be halted prematurely.
- Published in:
- 2014
- By:
- Publication type:
- Opinion
MIF homolog d-dopachrome tautomerase (D-DT/MIF-2) does not inhibit accumulation and toxicity of misfolded SOD1.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-13744-7
- By:
- Publication type:
- Article
A VDAC1-Derived N-Terminal Peptide Inhibits Mutant SOD1-VDAC1 Interactions and Toxicity in the SOD1 Model of ALS.
- Published in:
- Frontiers in Cellular Neuroscience, 2019, p. 1, doi. 10.3389/fncel.2019.00346
- By:
- Publication type:
- Article
Blocking an epitope of misfolded SOD1 ameliorates disease phenotype in a model of amyotrophic lateral sclerosis.
- Published in:
- Brain: A Journal of Neurology, 2023, v. 146, n. 11, p. 4594, doi. 10.1093/brain/awad222
- By:
- Publication type:
- Article
CD4 T-cell aging exacerbates neuroinflammation in a late-onset mouse model of amyotrophic lateral sclerosis.
- Published in:
- Journal of Neuroinflammation, 2024, v. 21, n. 1, p. 1, doi. 10.1186/s12974-023-03007-1
- By:
- Publication type:
- Article
A Chemical Chaperone-Based Drug Candidate is Effective in a Mouse Model of Amyotrophic Lateral Sclerosis (ALS).
- Published in:
- ChemMedChem, 2015, v. 10, n. 5, p. 850, doi. 10.1002/cmdc.201500045
- By:
- Publication type:
- Article
Early upregulation of cytosolic phospholipase A<sub>2</sub>α in motor neurons is induced by misfolded SOD1 in a mouse model of amyotrophic lateral sclerosis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Empty mesoporous silica particles significantly delay disease progression and extend survival in a mouse model of ALS.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-77578-x
- By:
- Publication type:
- Article
Fluoxetine (Prozac) interaction with the mitochondrial voltage-dependent anion channel and protection against apoptotic cell death
- Published in:
- FEBS Letters, 2005, v. 579, n. 22, p. 5105, doi. 10.1016/j.febslet.2005.08.020
- By:
- Publication type:
- Article
Targeting the Mitochondrial Protein VDAC1 as a Potential Therapeutic Strategy in ALS.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 17, p. 9946, doi. 10.3390/ijms23179946
- By:
- Publication type:
- Article
4-Phenylbutyric Acid (4-PBA) Derivatives Prevent SOD1 Amyloid Aggregation In Vitro with No Effect on Disease Progression in SOD1-ALS Mice.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 16, p. 9403, doi. 10.3390/ijms23169403
- By:
- Publication type:
- Article